Nonmelanoma Skin Cancer

Offering image-guided superficial radiation therapy to rural populations could mend health disparities in nonmelanoma skin cancer treatment, according to a study published in Cancers.

The risk for melanoma-related death increased among patients with T1 melanoma tumors thicker than 0.8 mm, according to a study.

Metformin may have potential in preventing nonmelanoma skin cancer, including in most populations with skin of color, according to a study.

As the year comes to a close, Healio Dermatology has assembled this year’s most-read cutaneous oncology articles.

The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.

The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.

The FDA has granted breakthrough device designation to VIO Skin Platform, an AI-powered tool that evaluates suspicious lesions for skin cancer, Enspectra Health announced in a press release.

As April is Skin Cancer Awareness Month, Healio has compiled the top skin cancer news and stories from 2024.

MIAMI BEACH, Fla. — Patients who are elderly or are poor candidates for surgery with nonmelanoma skin cancer would benefit from superficial radiation therapy, according to a speaker at South Beach Symposium.